Machine Learning Approaches in Drug Development of HIV/AIDS

III. Involving T-cell responses: Another therapeutic vaccine in development is designed to include CD4+ T cell responses in HIV infected people. CD4+ T cells play a important role in immune protection against viral infections. Deficits in CD4+ t cells are associated with virus reactivation, vulnerability to opportunistic infections and poor vaccine efficacy. For HIV/ AIDS, the introduction of novel therapeutics and continuous research into their best use in patients have revealed the result of the development and introduction of multiple drugs (used in combinations i.e. anti retroviral drugs) are proven good in health of HIV infected patients. As there is currently no publicly available vaccine or cure for HIV or AIDS [1]. Some examples include a vaginal gel containing tenofovir, a reverse transcriptase inhibitor is developed showing good results in clinical trials [2].